EKSOEkso Bionics Holdings, Inc.

$29M

Q4 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4M+80.8% YoY

Gross Profit

$2M59.2% margin

Operating Income

-$5M-111.7% margin

Net Income

-$3M-70.2% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+33.7%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$821,000

Balance Sheet

Total Assets

$49M

Total Liabilities

$12M

Stockholders' Equity

$37M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+80.8%
Gross Profit	$2M	$1M	+77.4%
Operating Income	-$5M	-$3M	-51.9%
Net Income	-$3M	-$4M	+28.0%

Revenue Segments

EksoHealth

$3M84%

EksoWorks

$632,00016%

EKSO Q4 2021 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena